These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24344483)

  • 1. Icodextrin eliminates phosphate and ameliorates cardiac hypertrophy and valvular calcification in patients with end-stage renal disease and diabetes mellitus undergoing peritoneal dialysis.
    Hiramatsu T; Hayasaki T; Hobo A; Furuta S; Kabu K; Tonozuka Y; Iida Y
    Adv Perit Dial; 2013; 29():9-13. PubMed ID: 24344483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icodextrin-based continuous ambulatory peritoneal dialysis therapy effectively reduces left ventricular mass index and protects cardiac function in patients with end-stage renal disease.
    Oba I; Shinozaki M; Harada K; Mori T; Kanai H
    Adv Perit Dial; 2013; 29():14-8. PubMed ID: 24344484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When should icodextrin be started to improve atherosclerosis in peritoneal dialysis patients?
    Hiramatsu T; Hayasaki T; Hobo A; Furuta S; Kabu K; Tonozuka Y; Iida Y
    Adv Perit Dial; 2013; 29():4-8. PubMed ID: 24344482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icodextrin and peritoneal dialysis: advantages and new applications.
    Dousdampanis P; Musso CG; Trigka K
    Int Urol Nephrol; 2018 Mar; 50(3):495-500. PubMed ID: 28674854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients.
    Wang IK; Li YF; Chen JH; Liang CC; Liu YL; Lin HH; Chang CT; Tsai WC; Yen TH; Huang CC
    Nephrology (Carlton); 2015 Mar; 20(3):161-7. PubMed ID: 25487756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients.
    Furuya R; Odamaki M; Kumagai H; Hishida A
    Nephrol Dial Transplant; 2006 Feb; 21(2):494-8. PubMed ID: 16221697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients.
    Shang D; Xie Q; Ge X; Yan H; Tian J; Kuang D; Hao CM; Zhu T
    BMC Nephrol; 2015 Jul; 16():107. PubMed ID: 26187601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial to evaluate the effects of icodextrin on left ventricular mass index in peritoneal dialysis.
    Cordeiro L; Ishikawa WY; Andreoli MCC; Canziani MEF; Araujo LKRP; Pereira BJ; Abensur H; Moysés RMA; Elias RM
    Sci Rep; 2022 Sep; 12(1):15776. PubMed ID: 36138087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the use of icodextrin in peritoneal dialysis patients.
    Johnson DW; Agar J; Collins J; Disney A; Harris DC; Ibels L; Irish A; Saltissi D; Suranyi M
    Nephrology (Carlton); 2003 Feb; 8(1):1-7. PubMed ID: 15012742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
    Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis.
    Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
    Nephrol Dial Transplant; 2012 May; 27(5):2044-50. PubMed ID: 21968011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valvular calcification and left ventricular modifying in peritoneal dialysis patients.
    Rebić D; Rašić S; Hamzić-Mehmedbašić A; Džemidžić J; Kurtalić E
    Ren Fail; 2015; 37(8):1316-22. PubMed ID: 26287980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icodextrin: fifteen years and counting. Introduction.
    Blake PG
    Perit Dial Int; 2009; 29(4):367-9. PubMed ID: 19725196
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is intermittent peritoneal dialysis with icodextrin a valid option in the long-term treatment of refractory congestive heart failure?].
    Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
    G Ital Nefrol; 2009; 26 Suppl 46():44-9. PubMed ID: 19644817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of icodextrin versus glucose containing peritoneal dialysis in metabolic management of peritoneal dialysis patients.
    He Q; Zhang W; Chen J
    Ren Fail; 2011; 33(10):943-8. PubMed ID: 21929279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
    Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
    Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does coronary artery calcification in patients with diabetic nephropathy depend on the advancement of renal failure?
    Krzanowski M; Kuśnierz-Cabala B; Miarka P; Wójcik K; Stompór T; Sułowicz W
    Med Pregl; 2007; 60 Suppl 2():39-42. PubMed ID: 18928155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.